AVEO PHARMACEUTICALS, INC. (AVEO) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
EUSA				3.4	4.4
Other				2.0	3.2
Revenues	42.3	6.0	28.8	5.4	7.6	2.5	19.0	18.1
Revenue growth [+]	602.7%	-79.1%	432.4%	-28.6%	201.4%	-86.8%	5.0%	1301.6%
EUSA				-22.8%
Cost of goods sold	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	37.6	6.0	28.8	5.4	7.6	2.5	19.0	18.1
Gross margin	88.8%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Selling, general and administrative [+]	60.8	22.2	11.2	10.8	9.1	8.2	10.2	18.6
General and administrative					9.1	8.2	10.2	18.6
Research and development	26.3	22.7	18.0	20.7	25.2	23.7	12.9	38.3
Other operating expenses	0.2	4.9	11.6		2.1		4.0
EBITDA [+]	-49.7	-43.8				-29.4	1.5	-32.5
EBITDA growth	13.6%	266.1%	-54.1%	-9.7%	-1.9%	-2058.8%	-104.6%	-64.7%
EBITDA margin	-117.5%	-726.9%	-41.5%	-481.1%	-380.1%	-1167.5%	7.9%	-179.3%
Depreciation and amortization	0.1	0.0				0.0	9.6	6.2
EBIT [+]	-49.8	-43.8	-12.0	-26.0	-28.8	-29.4	-8.1	-38.7
EBIT growth	13.7%	266.3%	-54.1%	-9.7%	-2.0%	264.3%	-79.2%	-59.6%
EBIT margin	-117.6%	-727.3%	-41.5%	-481.1%	-380.1%	-1168.7%	-42.4%	-213.7%
Non-recurring items [+]	-0.2	-4.9	-11.6	-0.7			4.4	11.7
Legal settlement				-0.7
Interest expense	4.0	1.6	1.8	2.2	2.4	1.9	2.3	2.4
Interest expense	4.0	1.6	1.8	2.2	2.4	1.9	2.3	2.4
Other income (expense), net [+]	0.3	4.9	11.6	22.2	-33.7	4.6	-0.3	0.1
Litigation settlement					2.1		4.0
Unrealized gain/loss on derivatives	0.2	4.9	11.6
Other non-operating income	0.1
Other	0.1			2.3		-0.2	-0.3	0.1
Pre-tax income	-53.3	-35.6	9.4	-5.3	-64.9	-26.8	-15.0	-52.7
Income taxes	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%			0.0%	0.0%
Net income	-53.3	-35.6	9.4	-5.3	-65.0	-26.9	-15.0	-52.7
Net margin	-126.1%	-591.2%	32.6%	-98.5%	-858.0%	-1069.1%	-78.9%	-291.0%

Basic EPS [+]	($1.63)	($1.66)	$0.61	($0.44)	($6.14)	($0.39)	($0.27)	($1.01)
Growth	-1.8%	-371.5%	-238.6%	-92.8%	1481.4%	44.1%	-73.3%	-52.0%
Diluted EPS [+]	($1.63)	($1.66)	$0.20	($0.41)	($6.14)	($0.39)	($0.27)	($1.01)
Growth	-1.8%	-916.1%	-150.0%	-93.4%	1481.4%	44.1%	-73.3%	-52.0%

Shares outstanding (basic) [+]	32.7	21.4	15.3	12.1	10.6	69.3	55.7	52.3
Growth	52.6%	39.6%	27.1%	13.8%	-84.7%	24.4%	6.5%	2.7%
Shares outstanding (diluted) [+]	32.7	21.4	46.1	13.1	10.6	69.3	55.7	52.3
Growth	52.6%	-53.6%	252.5%	23.4%	-84.7%	24.4%	6.5%	2.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.